PP2A fulfills its promises as tumor suppressor Which subunits are important? by Van Hoof, Christine & Goris, Jozef
CANCER CELL : FEBRUARY 2004 · VOL. 5 · COPYRIGHT © 2004 CELL PRESS 105
In an effort to determine the precise
combinations of mutations that program
human tumor cell growth, experimental
human cell lines are developed that
escape the irreversible growth arrest and
subsequent apoptosis, known as replica-
tive senescence and “crisis,” respective-
ly. By introduction of the gene encoding
the catalytic subunit of human telomer-
ase (hTERT) in combination with the
SV40 early region (ER) encoding the
large t (LT) and small t (ST) antigens,
immortalized human cell lines were
obtained. By co-expression of an onco-
genic allele of the H-ras gene, these cells
became tumorigenic. hTERT is neces-
sary to compensate the difference in
telomere biology between human and
rodent cells that express a constitutive
telomerase activity. LT sequesters and
inactivates the tumor suppressors pRB
and p53, whereas ST is absolutely
required for the transformation and
tumorigenicity of these cells.
Interaction of ST with the
Ser/Thr phosphatase PP2A
was essential since a mutant
ST, not binding PP2A, was
inactive in the process (Chen
et al., 2004, and references
herein).
PP2A is a family of abun-
dantly expressed Ser/Thr
phosphatases, implicated in a
multitude of cellular functions.
The PP2A core structure con-
sists of a catalytic subunit
(PP2AC) and a A/PR65 scaf-
fold protein. This core dimer
can recruit a third regulatory
B subunit. There are three
families of B subunits: B/B55/
PR55, B′/B56/PR61, and B′′/
PR72. Each PP2A subunit
has at least two isoforms. The
differential association of all
these subunits gives rise to an
extensive subset of oligomer-
ic holoenzymes. It is widely thought that
PP2A exercises regulatory flexibility and
differential substrate specificity through
the specific association of the core dimer
with one of the three regulatory B sub-
units. Moreover, PP2A interacts with a
still growing number of cellular and viral
proteins and is regulated by posttransla-
tional modifications (see Janssens and
Goris, 2001, for an extensive review on
PP2A).
Building further on the knowledge of
the elements in the ER of SV40, neces-
sary for human cell transformation, Chen
et al. investigated how ST deregulated
PP2A and subverted the cellular machin-
ery in order to become tumorigenic, as
reported in this issue of Cancer Cell
(Chen et al., 2004). Their observations
force us to renew our thinking about the
ST-PP2A interaction. Many groups con-
tributed to the idea that the core dimer of
PP2A is the only ST-interacting protein.
ST might directly interact with a 
preexisting dimer or displace a third
regulatory B subunit from a trimeric
holoenzyme. It was generally believed
that ST is able to replace the
B/B55/PR55, but not the B′/B56/PR61
subunit.This was based on the fact that in
vitro, recombinant ST could displace the
B/B55/PR55 subunit from purified
PP2AT55 trimeric enzyme, but not the
B′/B56/PR61 subunit from the purified
PP2AT61 trimer. Moreover, isolated
B′/B56/PR61 could displace B/B55/PR55
or ST from the corresponding PP2A
holoenzymes, whereas B/B55/PR55
could not (Kamibayashi and Mumby,
1995).
Now, Chen et al. (2004) reinvestigat-
ed this issue by following some functional
effects of suppressing one member of the
B/B55/PR55 (B55α) and one member of
the B′/B56/PR61 (B56γ) subunit family
and came to different conclusions. They
found that suppression of the
B56γ subunit expression, but
not downregulation of the
B55α subunit, mimics ST-
induced cell proliferation and
tumor formation. The authors
mentioned that downregula-
tion of B56γ as well as expres-
sion of ST reduced PP2A
activity by 43%.This suggests
that the PP2A-B56γ holoen-
zyme represents a substantial
proportion of the total PP2A
activity in vivo. This is surpris-
ing and might be related to the
assay method that is used.
Moreover, overexpression of
B56γ, but not B55α, partially
reverses ST-dependent,
anchorage- independent
growth and tumor formation.
Subsequently, in an attempt
to understand the molecular
mechanism of these ST
effects, they found that ST
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Reversible phosphorylation of proteins, catalyzed by kinases and phosphatases, is a key regulatory mechanism in the con-
trol of multiple cellular signal transduction pathways. Uncontrolled regulation by the altered phosphorylation state of the
components of these pathways often leads to increased cell proliferation and cell transformation. Many viruses encode
oncogenic proteins, required for their efficient viral replication, which deregulate the activity of host cell proteins. This
might program cells to a malignant state, underlying the molecular mechanism of tumor formation and cancer develop-
ment. Recent studies reveal a role for a specific form of protein phosphatase 2A (PP2A) in viral-induced cell transformation
by interaction with the small t antigen (ST) of the DNA tumor simian virus 40 (SV40).
Figure 1. Schematic representation of PP2A-ST interaction
Small t interaction with PP2A displaces the B′/B56/PR61γ regulatory
subunit, leading to an increased phosphorylation of specific PP2A-
B′/B56/PR61γ substrates. This results in an increased cell proliferation
and anchorage-independent growth, leading to tumor formation.
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displaces several B′/B56/PR61 isoforms
from the trimeric forms. ST also diplaces
the B/B55/PR55 subunit as previously
reported by others (Kamibayashi and
Mumby, 1995), although this PP2A trimer
does not participate in ST-induced cell
transformation in these experimental cell
lines. Finally, in 10 investigated lung can-
cer cell lines, no B′/B56/PR61γ protein
could be detected, and reintroduction of
B56γ, but not PR55α, partially reversed
the tumorigenic phenotype.
All these results further substantiate
the hypothesis that PP2A acts as a
tumor suppressor and it is Chen’s contri-
bution to define the PP2A-B′/B56/PR61γ
trimer as a specific target of ST-induced
cell transformation. This work also focus-
es on the amazing specificity of the
trimeric PP2As: although B′/B56/PR61α,
β, δ, and ε are highly similar in primary
structure and share approximately 68%
amino acid identity with B′/B56/PR61γ,
B56γ antisense RNA did not alter the
expression of the other isoforms.
Previously, Ito and coworkers (see Ito et
al., 2003, and references therein)
already observed that truncation of B56γ
leads to an enhanced invasiveness and
neoplastic progression, transforming
melanoma cells from a nonmetastatic to
a metastatic state. This argues again 
for the specific involvement of the
B′/B56/PR61γ subunit in tumor forma-
tion. Other groups also contributed to the
idea of PP2A being a tumor suppressor.
The first strong indication came from the
observation that the major cellular target
of the tumor promoter okadaic acid is
PP2A (Janssens and Goris, 2001).
Subsequently, mutations in the PR65/A
scaffold protein were detected in some
cancers (Wang et al., 1998), and others
found that these mutations interfered
with the binding of specific third regulato-
ry B subunits (Ruediger et al., 2001). A
completely different angle came from the
group of Damuni (Li et al., 1996), who
identified SET, a protein that is fused to
CAN in acute nonlymphocytic myeloid
leukemia, as one of the heat-stable spe-
cific PP2A protein inhibitors. Therefore,
disturbing the normal functioning of
PP2A might contribute to leukemogene-
sis. It is known that the B′/B56/PR61
subunit binds to the adenomatous poly-
posis coli (APC) tumor suppressor,
which is a component of the Wnt signal-
ing pathway (Seeling et al., 1999), and to
cyclin G, a regulator of mdm2 and 
p53 activity (Okamoto et al., 2002).
Interestingly, both loss-of-function muta-
tions of APC and overexpression of
cyclin G are involved in colon cancer.
Hence, the PP2A B′/B56/PR61 subunit
might contribute to cancer development
by direct interaction to APC and cyclin G.
PP2A has been implicated in the regula-
tion of cell cycle progression, DNA
replication, transcription, and protein
translation, and could therefore also be a
causative factor in genetic instability.
Surprisingly, the authors did not
observe any functional effect of down-
regulation of the B/B55/PR55 subunit.
Does this mean that PR55 is not involved
in the action of ST? Certainly not. Also,
Chen and coworkers (Chen et al., 2004)
found that ST displaced PR55 from the
trimeric holoenzyme, but it seems not to
contribute to transformation in their cellu-
lar model. In a simpler cell system,
where only ST is expressed, PP2A-
B/B55/PR55 is redistributed, resulting in
an alteration in the actin cytoskeleton
and deregulation of the tight junctions,
known to play a role in cell adhesion and
cancer metastasis (Nunbhakdi-Craig et
al., 2003).
In conclusion, it can be said that
Chen et al. (2004) succeeded in creating
a human cell line that recapitulates most
of the cellular changes that can lead to
cancerous growth and pinpointed the
B′/B56/PR61γ subunit of PP2A as a cru-
cial player in transformation and tumori-
genesis. However, the actual regulation
of the PP2A-B′/B56/PR61γ activity
toward specific target proteins still
remains to be elucidated. The action of
the oncogenic viral protein SV40 ST
implicitly indicates that “third” subunit
shuffling is possible, suggesting that
such mechanisms also operate in nor-
mal cellular conditions. Also, partners in
these mechanisms might be targets for
therapeutic intervention.
A model for the involvement of a spe-
cific PP2A holoenzyme in ST-induced
cell transformation is given in Figure 1.
However, the molecular mechanism and
particular signaling pathways participat-
ing in cell transformation and affected by
ST-PP2A interaction remain to be eluci-
dated. Probably, cell transformation
results from an altered phosphorylation
state of PP2A-specific substrates.
Alternatively, ST changes the subcellular
localization of particular PP2A holoen-
zymes or affects the interaction of PP2A
with cellular proteins such as APC or
cyclin G. One of the potential PP2A-ST
targets causing cell transformation might
be Akt, since the phosphatidylinositol 3-
kinase (PI3-K)/Akt signaling cascade is
activated by ST (Zhao et al., 2003).
PP2A is a major kinase phosphatase
and several groups mentioned Akt 
as a PP2A substrate. Identification of 
specific PP2A-B′/B56/PR61γ3 sub-
strates involved in ST-induced cell trans-
formation will be of major interest to
solve this problem.
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